Randomised Phase II Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population (rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV).
Latest Information Update: 06 Jul 2023
At a glance
- Drugs AZD 1222 (Primary) ; BBIBP CorV (Primary) ; COVID-19 vaccine-Gamaleya National Research Center of Epidemiology and Microbiology (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
- 06 Aug 2021 New trial record